The U.S. Senate may consider an amendment next week that would require federal agencies to conduct a study on how marijuana legalization is impacting states that have adopted it.
The measure, filed on Thursday by Sen. Robert Menendez (D-NJ), would direct the Departments of Justice, Labor and Health and Human Services to contract with the National Academy of Sciences for a 10-year examination of “monetary amounts generated” by legal cannabis tax revenue, as well as “rates of medicinal use” and “rates of overdoses with opioids and other painkillers” in states with some form of legalization, among other datapoints.
“The need for Congress to pull its head from the sand regarding the implications of functional regulated marijuana markets is dire,” Justin Strekal, political director for NORML, told Marijuana Moment. “No senator can intellectually justify remaining willfully ignorant to the results of successful state-legal programs and the National Academy of Sciences can prove to be the neutral arbitrator in assessing the real world impact that is happening in 31 medical or adult-use states throughout the country.”
The Senate amendment’s text is similar to standalone House legislation that Reps. Tulsi Gabbard (D-HI, Carlos Curbelo (R-FL) and others filed last month.
Watch Congresswoman Tulsi Gabbard And Other Federal Reps File New Marijuana Bill
The senator is seeking to attach the language to a bill to fund parts of the federal government, including the Departments of Defense, Labor, Education and Health and Human Services, for Fiscal Year 2019. The legislation has been on the floor this week, with consideration expected to resume on Monday.
Menendez’s Senate proposal isn’t identical to Gabbard’s House bill, as it leaves out directives from the earlier legislation for federal agencies to study legalization’s impact on criminal justice and employment. Advocates said that those sections weren’t germane to the title of the appropriations bill the senator is seeking to amend, and therefore had to be excluded.
Separately from the amendment, the senator plans to file a standalone companion bill containing the full text of the Marijuana Data Collection Act, his communications director, Patricia Enright, told Marijuana Moment in an email.
“Senator Menendez believes that as more and more states, including New Jersey, legalize medical or recreational marijuana, it makes good sense that we provide for independent, science-based research and analysis of current legalization policies and their impacts on communities,” she said. “If federal policy-makers are going to be a productive part of the conversation moving forward, it’s important that they be informed by objective, evidence-based data.”
For now, it is not clear if the Menendez amendment will be debated or receive a vote on the Senate floor before the body finalizes the spending legislation.
See the original article published on Marijuana Moment below:
Senate Amendment Requires Feds To Study Marijuana Legalization’s Impact
States where people can legally access marijuana through dispensaries see dramatically reduced opioid overdose death rates, new federally funded research shows.
“In short, our findings that legally protected and operating medical marijuana dispensaries reduce opioid-related harms suggests that some individuals may be substituting towards marijuana, reducing the quantity of opioids they consume or forgoing initiation of opiates altogether,” the study concludes. “Marijuana is a far less addictive substance than opioids and the potential for overdosing is nearly zero.”
While previous research has shown that medical marijuana laws are associated with lower opioid overdose rates, the new analysis distinguished between states where medical cannabis is simply legal and states that actually allow streamlined patient access to marijuana through active dispensaries.
“Because legal protection of retail dispensaries does not mean dispensaries are operational, we construct our policy measure to identify the state/year in which dispensaries are both legally protected and open for business,” researchers from the RAND Corporation, the National Bureau of Economic Research and the University of California, Irvine wrote. “Dispensaries – retail outlets that sell marijuana to qualified patients – contribute to the decline in opioid overdose death rates.”
To be more specific:
“Using data from just the early period of these laws 1999–2010, dispensaries reduce opioid mortality rates by about 40%, above and beyond the reduction from marijuana laws alone. The total effect is estimated to be even larger. When we consider the full time period (1999–2013), the estimates imply that dispensaries reduce opioid mortality rates by about 20% while the main effect of having a law is relatively small in magnitude, implying declines of about 5%, and not statistically distinguishable from zero. Importantly, together – a marijuana law with a legal, operational dispensary provision – the estimates imply a statistically significant (at the 5% level) decline in overdose death rates of about 25%.”
“It is clear that operational dispensaries are critical,” the study, published online over the weekend by the Journal of Health Economics, concluded. “This evidence is consistent with the need for a clear and legal supply chain for medical marijuana policy to have an effect.”
Going a step further, the study, which was funded by the National Institute on Drug Abuse, found that examining data from after 2010, “a period when states began opening more tightly regulated medical marijuana retail systems,” apparently in response to federal enforcement guidance, weakens the effect.
“The effect of medical marijuana policies on opioid related harm diminishes over time, particularly after 2010, which might be due to the regulatory tightening of medical marijuana dispensaries, the major marijuana policy feature behind the reduced harm in the earlier period,” the data suggests.
Nonetheless, the researchers concluded that “our results suggest a potential overlooked positive effect of medical marijuana laws that support meaningful retail sales.”
See the original article published on Marijuana Moment below:
Medical Marijuana Dispensaries Save Lives, Study Finds